Drug delivery to central nervous system (CNS) diseases is very challenging since the
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …

Nanotechnology has been a boon for the biomedical field due to the freedom it provides for
tailoring of pharmacokinetic properties of different drug molecules. Nanomedicine is the …

Neurodegenerative diseases are common, incurable neurological disorders with high
prevalence, and lead to memory, movement, language, and intelligence impairments …

Even though Parkinson's disease (PD) is the second most common neurological disorder
(ND), it faces an absence of credible drug delivery, treatment and diagnosis. Levodopa is …

Cerium oxide nanoparticles (CeONPs) have come to prominence as a highly intriguing and
beneficial nanomaterial in an array of biomedical and theranostic applications, including …

Amyloid aggregation is a ubiquitous form of protein misfolding underlying the pathologies of
Alzheimer's disease (AD), Parkinson's disease (PD), and type 2 diabetes (T2D), three …

The prevalence of the two most common neurodegenerative diseases, Parkinson's disease
(PD) and Alzheimer's Disease (AD), are expected to rise alongside the progressive aging of …

Increasing brain disease incidence has become a common cause of disability and death
worldwide. Early diagnosis of brain diseases is crucial to improve the prognosis of patients …

Introduction: Cerium oxide nanoparticles (CONPs) have been investigated for their
therapeutic potential in Parkinson's disease (PD) due to their potent and regenerative …

Dramatic advancement has been made in recent decades to understand the basis of
autoimmunity-mediated neurological diseases. These diseases create a strong influence on …